类风湿关节炎相关间质性肺病或支气管扩张患者的严重感染风险:一项比较队列研究
基于马萨诸塞州总医院布莱根生物样本库的回顾性队列研究,比较221例类风湿关节炎相关肺病(RA-LD,含151例RA-ILD与70例RA-BR)与980例无肺病RA患者。RA-LD严重感染风险显著升高(55.8 vs 25.8/1000人年;sdHR 1.60;95%CI 1.20-2.12),主要见于RA-ILD(sdHR 1.79;95%CI 1.33-2.41),RA-BR未达统计学显著(sdHR 1.19;95%CI 0.72-1.97)。
要点
- RA-LD患者严重感染发生率为55.8/1000人年,高于无肺病RA患者的25.8/1000人年。
- RA-ILD的严重感染风险升高(sdHR 1.79;95%CI 1.33-2.41),RA-BR未达统计学显著(sdHR 1.19;95%CI 0.72-1.97)。
- RA-LD中较常见的感染部位包括肺、皮肤软组织及耳鼻咽喉,病原涵盖病毒、细菌、真菌和分枝杆菌。
核心结论
- RA-LD,尤其是RA-ILD,与跨解剖部位、多种病原类型的严重感染风险显著升高相关;RA-BR与肺部感染增加相关。
- 作者认为需要前瞻性研究和试验来明确治疗RA-LD并降低感染风险的最佳方法。
研究设计与样本
- 回顾性队列研究,使用马萨诸塞州总医院布莱根生物样本库(美国马萨诸塞州波士顿)。
- 比较RA-LD与无肺病RA患者(RA-no LD),按年龄、性别和RA病程匹配。
- RA-LD病例经病历审查和胸部影像核实,为临床明显的RA相关间质性肺病(RA-ILD)和/或RA相关支气管扩张(RA-BR)。
- 共纳入221例RA-LD(151例RA-ILD和70例RA-BR)与980例RA-no LD对照。
- 主要结局为严重感染;采用Fine和Gray模型计算发生率及倾向评分校正的亚分布风险比(sdHR),以考虑死亡竞争风险。
主要发现
- RA-LD较RA-no LD对照的严重感染风险显著升高(55.8 vs 25.8/1000人年;sdHR 1.60;95%CI 1.20-2.12)。
- RA-ILD的严重感染风险升高(sdHR 1.79;95%CI 1.33-2.41)。
- RA-BR的严重感染风险未达统计学显著(sdHR 1.19;95%CI 0.72-1.97)。
- RA-LD中较常见的感染解剖部位包括肺、皮肤软组织及耳鼻咽喉;RA-LD与多种病原类型相关,包括病毒、细菌、真菌和分枝杆菌。
- 在RA-LD病例中,尤其RA-BR中频率较高的特定病原包括流感病毒、呼吸道合胞病毒、葡萄球菌属、假单胞菌属和非结核分枝杆菌。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者认为需要前瞻性研究和试验来明确治疗RA-LD并降低感染风险的最佳方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the association between rheumatoid arthritis-associated lung disease (RA-LD) and serious infection risk. METHODS: We conducted a retrospective cohort study using the Massachusetts General Brigham Biobank (Boston, MA, USA), comparing RA-LD with patients with RA without lung disease (RA-no LD), matched by age, sex, and RA duration. Cases of RA-LD were verified by medical record review and chest imaging for clinically apparent RA-associated interstitial lung disease (RA-ILD) and/or RA-associated bronchiectasis (RA-BR). The primary outcome was serious infection. Incidence rates and propensity score-adjusted subdistribution hazard ratios (sdHRs) were calculated using Fine and Gray models to account for competing risk of death. RESULTS: Among 221 patients with RA-LD (151 RA-ILD and 70 RA-BR) and 980 RA-no LD comparators, RA-LD had a significantly higher serious infection risk compared with RA-no LD comparators (55.8 vs 25.8 per 1,000 person-years; sdHR 1.60; 95% confidence interval [CI] 1.20-2.12). The increased risk remained significant for those with RA-ILD (sdHR 1.79; 95% CI 1.33-2.41) but not for RA-BR (sdHR 1.19; 95% CI 0.72-1.97). Anatomic sites of infection that were more common in RA-LD included pulmonary, skin and soft tissue, and ear, nose, and throat; RA-LD was associated with various pathogen types, including virus, bacteria, fungus, and mycobacteria. Specific pathogens with higher frequency in cases of RA-LD, particularly among RA-BR, included influenza virus, respiratory syncytial virus, Staphylococcus, Pseudomonas, and nontuberculous mycobacteria. CONCLUSION: RA-LD, particularly RA-ILD, is associated with a significant increased risk of serious infection across anatomic sites and diverse pathogen types. RA-BR is associated with increased pulmonary infections. Prospective studies and trials are needed to clarify optimal approaches to treat patients with RA-LD and reduce infection risk.
引用
- Zhang Q, Qi Y, Wang X, et al. Risk of Serious Infection in Patients With Rheumatoid Arthritis-Associated Interstitial Lung Disease or Bronchiectasis: A Comparative Cohort Study. Arthritis Rheumatol. 2025. PMID: 40708472. doi:10.1002/art.43338
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。